HLB Life Science, Individual Investors Focused... Stock Price -7.39%...
Recently, there has been a surge in search frequency for HL Biopharma, known as an engineering service company related to energy saving.
As of 12:32 PM on the 22nd, the stock price of HL Biopharma is 31,950 KRW, down 7.39% from the previous day, with a trading volume of 3,239,761 shares, which is about 57.56% of the 5-day average trading volume. Foreign investors are tentatively reported to have net purchased 10,000 shares today.
On September 21, HL Biopharma became a market issue with a 21% increase following the Phase 3 clinical trial results of 'Riboceranib'.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
